Argenx Se (ARGX) Receivables (2015 - 2026)

Argenx Se (ARGX) posted quarterly Receivables of $1.9 billion for Q2 2026, down 99.84% year-on-year from $1197.1 billion in Q2 2025, and up 17.24% on a QoQ basis from $1.6 billion in Q4 2025.

Argenx Se (ARGX) Receivables (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Receivables for 12 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

  • Quarterly Receivables fell 99.84% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (down 99.84% YoY) and the FY2025 annual result came in at $1.6 billion, up 80.96% from the prior year.
  • Receivables improved to $1.9 billion in Q2 2026 per ARGX's latest filing, from $1.6 billion in the prior quarter.
  • Over the last five years, Receivables for ARGX reached as high as $1197.1 billion in Q2 2025 and fell as low as $112.4 million in Q2 2022.
  • A 5-year average of $133.7 billion and a median of $710.4 million in 2024 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2025 — Receivables surged 168409.35% — and 2026, when it plunged 99.84%.
  • Year by year, Receivables stood at $276.7 million in 2022, then surged by 80.2% to $498.6 million in 2023, then surged by 82.52% to $910.1 million in 2024, then surged by 80.96% to $1.6 billion in 2025, then increased by 17.24% to $1.9 billion in 2026.
  • According to Business Quant data, Receivables over the past three periods registered $1.9 billion, $1.6 billion, and $1197.1 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 883.96 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.93 Bn
Dec 31, 2025 1.65 Bn
Jun 30, 2025 1,197.07 Bn
Dec 31, 2024 910.14 Mn
Jun 30, 2024 710.39 Mn
Dec 31, 2023 498.65 Mn
Jun 30, 2023 382.79 Mn
Dec 31, 2022 276.72 Mn
Jun 30, 2022 112.39 Mn
Dec 31, 2021 39.09 Mn
Jun 30, 2021 12.05 Mn
Dec 31, 2020 11.76 Mn
Jun 30, 2020 9.74 Mn
Dec 31, 2019 35.92 Mn
Jun 30, 2019 6.30 Mn
Dec 31, 2018 5.69 Mn
Jun 30, 2018 18.36 Mn
Dec 31, 2017 5.18 Mn
Jun 30, 2017 6.16 Mn
Dec 31, 2016 2.84 Mn